C. Vrech

发表

Immunogenicity of An Interferon-β1a Product

S. Grossberg, M. Kauffman, M. Papouchado, 2011, International journal of immunopathology and pharmacology.

Coronavirus disease 2019 in Latin American patients with multiple sclerosis

M. Sormani, Y. Fragoso, I. Schiavetti, 2021, Multiple Sclerosis and Related Disorders.

Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group.

Y. Fragoso, A. Carrá, D. Vizcarra, 2022, Multiple sclerosis and related disorders.

Clinical and demographic characteristics of male MS patients included in the national registry –RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?

J. Correale, L. Recchia, A. Carrá, 2021, Multiple Sclerosis and Related Disorders.

Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina.

A. Carrá, F. Caceres, E. Cristiano, 2020, Multiple sclerosis and related disorders.

Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina

J. Correale, J. Criniti, A. Carrá, 2022, Neurological Sciences.

The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions.

J. Correale, A. Carrá, E. Cristiano, 2019, Multiple sclerosis and related disorders.

Consensus recommendations on the management of multiple sclerosis patients in Argentina

J. Correale, F. Caceres, E. Cristiano, 2019, Journal of the Neurological Sciences.

Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM

J. Correale, L. Recchia, A. Carrá, 2021, Journal of Clinical Neuroscience.

Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients

J. Correale, A. Carrá, F. Caceres, 2018, Journal of the Neurological Sciences.

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America

A. Carrá, E. Cristiano, O. Garcea, 2021, Multiple Sclerosis and Related Disorders.

What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).

J. Correale, A. Carrá, E. Cristiano, 2021, Multiple sclerosis and related disorders.

Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

A. Carrá, G. Luetic, V. Sinay, 2008, European journal of neurology.

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

H. Atkins, J. Lechner-Scott, M. Onofrj, 2023, JAMA neurology.

Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies

E. Cristiano, N. Fernández Liguori, O. Garcea, 2023, Multiple sclerosis journal - experimental, translational and clinical.

Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina.

J. Correale, A. Carrá, E. Cristiano, 2022, Multiple sclerosis and related disorders.

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.

F. Paul, J. Correale, J. Criniti, 2021, Multiple sclerosis and related disorders.

Absence of latitudinal gradient in oligoclonal bands prevalence in Argentina.

J. Correale, L. Recchia, A. Carrá, 2020, Multiple sclerosis and related disorders.

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

J. Correale, A. Carrá, E. Cristiano, 2020, Neurological Sciences.

Delay from treatment start to full effect of immunotherapies for multiple sclerosis.

L. Kappos, P. Vermersch, E. Leray, 2020, Brain : a journal of neurology.

Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue

A. Carrá, E. Cristiano, N. Fernández Liguori, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina

F. Paul, J. Correale, J. Criniti, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Corrigendum to “Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients” [J. Neurol. Sci. 385C (2018) 217–224]

J. Correale, A. Carrá, E. Cristiano, 2018, Journal of Neurological Sciences.

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.

J. Correale, E. Cristiano, G. Luetic, 2023, Multiple sclerosis.

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM.

A. Carrá, E. Cristiano, O. Garcea, 2021, Multiple sclerosis and related disorders.

Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM

J. Correale, A. Carrá, E. Cristiano, 2022, Multiple Sclerosis and Related Disorders.

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry

J. Criniti, E. Cristiano, N. Fernández Liguori, 2023, Multiple sclerosis journal - experimental, translational and clinical.